C14orf37_3632451O06Rik Activators
C14orf37 Activators are a diverse array of chemical compounds that facilitate the enhancement of C14orf37 through distinct yet interrelated signaling pathways. Forskolin and 8-Br-cAMP, by increasing intracellular cAMP levels, activate PKA, which may subsequently phosphorylate and enhance the activity of C14orf37 by promoting CREB-mediated transcription processes specific to pathways where C14orf37 is a participant. Similarly, IBMX contributes to this enhancement by inhibiting phosphodiesterases, thereby stopping the degradation of cAMP and allowing PKA-mediated signaling to prevail, which could influence C14orf37 activity. The PKC activators, PMA (also known as TPA) and the calcium ionophores Ionomycin and A23187, induce signaling cascades by increasing intracellular calcium, which could activate calcium-dependent kinases, resulting in the enhancement of C14orf37 activity.
Further contributing to the activation of C14orf37 are LY294002, a PI3K inhibitor, and U0126, a MEK inhibitor, which mayC14orf37 Activators are a diverse array of chemical compounds that facilitate the enhancement of C14orf37 through distinct yet interrelated signaling pathways. Forskolin and 8-Br-cAMP, by increasing intracellular cAMP levels, activate PKA, which may subsequently phosphorylate and enhance the activity of C14orf37 by promoting CREB-mediated transcription processes specific to pathways where C14orf37 is a participant. Similarly, IBMX contributes to this enhancement by inhibiting phosphodiesterases, thereby hindering the degradation of cAMP and allowing PKA-mediated signaling to prevail, which could influence C14orf37 activity. The PKC activators, PMA (also known as TPA) and the calcium ionophores Ionomycin and A23187, induce signaling cascades by increasing intracellular calcium, which could activate calcium-dependent kinases, resulting in the enhancement of C14orf37 activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Br-cAMP is a cAMP analog that activates PKA. The activation of PKA can lead to the phosphorylation of proteins in signaling pathways where C14orf37 is involved, resulting in its functional enhancement. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP, leading to their accumulation. This can potentiate the PKA pathway, indirectly enhancing the activity of C14orf37. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which is involved in numerous signaling cascades. PKC activation can lead to downstream effects that enhance the activity of C14orf37. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration, indirectly activating calcium-dependent kinases and phosphatases that could enhance C14orf37 activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore similar to Ionomycin. It increases intracellular calcium levels, which can activate signaling pathways involving calmodulin and calcium/calmodulin-dependent protein kinase, potentially enhancing the activity of C14orf37. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that may enhance C14orf37 activity by reducing competitive signaling pathways and thereby allowing activation of pathways where C14orf37 is involved. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that can inhibit several protein kinases, potentially leading to the activation of alternative pathways that could enhance the functional activity of C14orf37. | ||||||